INTS

Intensity TherapeuticsF

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

RSI (14)

41.6

Neutral

MACD Hist

-0.03

Bearish

ATR (14)

0.24

Normal

Vol Z (20)

-0.61

Normal

RET 20D

+1.5%

Positive

Dist 52W High

-87.8%

Below High

Technical chart

1 Year

Candles, moving averages, and volume using the current RankAlpha theme.

As of 2026-09-11

Price

SMA 20

SMA 50

SMA 200

Trend readout

Technical readout

Trend

Downtrend (SMA20 < SMA50 < SMA200)

Momentum

Positive momentum · 20D +1.5% · 60D +9.4%

RSI / MACD

RSI 41.6 (Neutral) · MACD hist -0.03

Volatility

Volatility normal (Z -0.61)

SMA20

4.28

SMA50

4.39

SMA200

6.47

EMA12

4.14

EMA26

4.23

BB Upper

4.90

BB Mid

4.28

BB Lower

3.65

RET 5D

-2.0%

RET 20D

+1.5%

RET 60D

+9.4%

RET 120D

-35.4%

As of 2026-09-11 • Updated nightlySource: Internal modelMethods & Data